Long-term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with Lewy bodies

Psychogeriatrics

Volumn 15, Issue 2, 2015, Pages 133-137

  Ukai, Katsuyuki ^a,b   Fujishiro, Hiroshige ^b   Iritani, Shuji ^b   Ozaki, Norio ^b  

^a Kamiiida Daiichi General Hospital   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Appropriate dose; Cholinesterase inhibitor; Dementia with Lewy bodies (DLB); Donepezil; Pharmacotherapy; Visual hallucinations

Indexed keywords

DONEPEZIL; MEMANTINE; NOOTROPIC AGENT; RISPERIDONE; UNCLASSIFIED DRUG; YOKUKANSAN;

ABNORMAL BEHAVIOR; ADJUVANT THERAPY; AGED; ALZHEIMER DISEASE ASSESSMENT SCALE; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN BLOOD FLOW; CLINICAL ARTICLE; DELUSION; DIFFUSE LEWY BODY DISEASE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MYOCARDIAL PERFUSION IMAGING; OCCIPITAL LOBE; OFF LABEL DRUG USE; PARIETAL LOBE; PRIORITY JOURNAL; RELAPSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VERY ELDERLY; VISUAL HALLUCINATION;

EID: 84930748368     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/psyg.12089     Document Type: Article

References (21)

1. Kosaka K, Oyanagi S, Matsushita N, Hori A, Iwase S. Presenile dementia with Alzheimer-, Pick- and Lewy body changes. Acta Neuropathol 1976; 36: 221-233.
2. Kosaka K, Mehraein P. Dementia-Parkinsonism syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nervenkr 1979; 226: 241-250.
3. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: a new disease? Clin Neuropathol 1984; 3: 185-192.
4. McKeith IG, Galasko D, Kosaka K etal. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 1996; 47: 1113-1124.
5. McKeith IG, Dickson DW, Lowe J etal. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB Consortium. Neurology 2005; 65: 1863-1872.
6. Allen RL, Walker Z, D'Ath PJ etal. Risperidone for psychotic and behavioral symptoms in Lewy body dementia. Lancet 1995; 346: 185.
7. Cummings JL, Street J, Masterman D etal. Efficacy of olanzapine in the treatment of psychosis in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2002; 13: 67-73.
8. Fergusson E, Howard R. Donepezil for the treatment of psychosis in dementia with Lewy bodies. Int J Geriatr Psychiatry 2000; 15: 280-281.
9. Ikeda M, Mori E, Kosaka K etal. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Dement Geriatr Cogn Disord 2013; 36: 229-241.
10. Kosaka K. Behavioral and psychological symptoms of dementia (BPSD) in dementia with Lewy bodies. Psychogeriatrics 2008; 8: 134-136.
11. Lanctot KL, Herrmann N. Donepezil for behavioral disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry 2000; 15: 338-345.
12. McKeith I, Del Ser T, Spano P etal. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031-2036.
13. Mori S, Mori I, Iseki E, Kosaka K. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open- label study. Psychiatry Clin Neurosci 2006; 60: 190-195.
14. Mori E, Ikeda M, Kosaka K. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol 2012; 72: 41-52.
15. Manabe Y, Kosaka K. Efficacy of high-dose donepezil in the treatment of neuropsychiatric symptoms in cases of dementia with Lewy bodies. Clinical Psychiatry 2009; 51: 1165-1172 (in Japanese with English abstract).
16. Rajas-fernandez CH. Successful use of donepezil for the treatment of dementia with Lewy bodies. Ann Pharmacother 2001; 35: 202-205.
17. Ukai K, Matsuo K, Nakamura R etal. A case of dementia with Lewy bodies that temporarily showed symptoms similar to Creutzfeldt-Jakob disease. Psychogeriatrics 2010; 10: 201-205.
18. Ukai K, Aleksic B, Ishihara R etal. Efficacy of donepezil for the treatment of visual and multiple sensory hallucinations in dementia with Lewy bodies. Clin Neuropharmacol Ther 2011; 2: 56-58.
19. Perry EK, Haroutunian V, Davis KL etal. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuro Rep 1994; 5: 747-749.
20. Iwasaki K, Kosaka K, Mori H etal. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine. Psychogeriatrics 2012; 12: 235-241.
21. Emre M, Tsolaki M, Bonuccelli U etal. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9: 969-977.